左乙拉西坦注射液FDA说明书.pdf

左乙拉西坦注射液FDA说明书.pdf

ID:56731042

大小:53.23 KB

页数:6页

时间:2020-07-06

左乙拉西坦注射液FDA说明书.pdf_第1页
左乙拉西坦注射液FDA说明书.pdf_第2页
左乙拉西坦注射液FDA说明书.pdf_第3页
左乙拉西坦注射液FDA说明书.pdf_第4页
左乙拉西坦注射液FDA说明书.pdf_第5页
资源描述:

《左乙拉西坦注射液FDA说明书.pdf》由会员上传分享,免费在线阅读,更多相关内容在应用文档-天天文库

1、Zemplar™(paricalcitolinjection)FliptopVialDESCRIPTIONZemplar™(paricalcitolinjection)isasyntheticallymanufacturedvitaminDanalog.Itisavailableasasterile,clear,colorless,aqueoussolutionforintravenousinjection.EachmLcontainsparicalcitol,5mcg;propyleneglycol

2、,30%(v/v);andalcohol,20%(v/v).Paricalcitolisawhitepowderchemicallydesignatedas19-nor-1a,3ß,25-trihydroxy-9,10-secoergosta-5(Z),7(E),22(E)-trieneandhasthefollowingstructuralformula:CH3OHHOOHMolecularformulaisC27H44O3.Molecularweightis416.65.CLINICALPHARM

3、ACOLOGYMechanismofActionParicalcitolisasyntheticvitaminDanalog.VitaminDandparicalcitolhavebeenshowntoreduceparathyroidhormone(PTH)levels.PharmacokineticsDistributionThepharmacokineticsofparicalcitolhavebeenstudiedinpatientswithchronicrenalfailure(CRF)re

4、quiringhemodialysis.Zemplar™isadministeredasanintravenousbolusinjection.Withintwohoursafteradministeringdosesrangingfrom0.04to0.24mcg/kg,concentrationsofparicalcitoldecreasedrapidly;thereafter,concentrationsofparicalcitoldeclinedlog-linearlywithameanhal

5、f-lifeofabout15hours.Noaccumulationofparicalcitolwasobservedwithmultipledosing.EliminationInhealthysubjects,plasmaradioactivityafterasingle0.16mcg/kgintravenousbolusdose3ofH-paricalcitol(n=4)wasattributedtoparentdrug.Paricalcitolwaseliminatedprimarilyby

6、hepatobiliaryexcretion,as74%oftheradioactivedosewasrecoveredinfecesandonly16%wasfoundinurine.MetabolismSeveralunknownmetabolitesweredetectedinboththeurineandfeces,withnodetectableparicalcitolintheurine.Thesemetaboliteshavenotbeencharacterizedandhavenotb

7、eenidentified.Together,thesemetabolitescontributed51%oftheurinaryradioactivityand59%ofthefecalradioactivity.Invitroplasmaproteinbindingofparicalcitolwasextensive(>99.9%)andnonsaturableovertheconcentrationrangeof1to100ng/mL.ParicalcitolPharmacokineticCha

8、racteristicsinCRFPatients(0.24mcg/kgdose)ParameternValues(Mean±SD).Cmax(5min.afterbolus)61850±664(pg/mL)-AUC0527382±8230(pg•hr/mL)CL50.72±0.24(L/hr)Vss56±2(L)LaboratoryTestsInplacebo-controlledstudies,paricalcitolreducedserumtota

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。